No association between atopic outcomes and type of pertussis vaccine given in children born on the Isle of Wight 2001-2002

Carina Venter, Julia Stowe, Nicholas Andrews, Elizbeth Miller, Paul J. Turner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)
Original languageEnglish
Pages (from-to)1248-1250
Number of pages3
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume4
Issue number6
DOIs
Publication statusPublished - 1 Nov 2016

Bibliographical note

Funding Information:
Conflicts of interest: C. Venter has received research support from the National Institute for Health Research (NIHR) (grant reference no. NIHR/PDF/01/055); has received consultancy fees from Danone; has received lecture fees from Nestle; and has received payment for the development of educational presentations from Mead Johnson. J. Stowe and N. J. Andrews are employed by Public Health England and declare that Public Health England charges for reports to vaccine manufacturers on the impact of their vaccine on disease incidence. E. Miller has received research support from the Department of Health, National Vaccine Evaluation Consortium; is employed by Public Health England; and declares that Public Health England charges for reports to vaccine manufacturers on the impact of their vaccine on disease incidence. P. J. Turner has received consultancy fees from Reacta Biotech and UK Food Standards Agency; is employed by Public Health England and Imperial College London; has received research support from Medical Research Council, NIHR/Imperial Biomedical Research Centre, European Union FP7 Programme, and the UK Department of Health; has received travel support from the National Institute for Health and Care Excellence; and declares that Public Health England charges for reports to vaccine manufacturers on the impact of their vaccine on disease incidence. Clinical Communications

Cite this